OMND — Optimind Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Optimind Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2023 February 28th	2024 February 29th	2025 February 28th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.007	0.001	0.552	0.029	0.084
Net Total Accounts Receivable
Net Total Receivables	—	—	0.116	0.159	0.066
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.011	0.022	0.668	0.188	0.15
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.095	0	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	0.011	0.022	1.35	0.238	0.2
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.088	0.188	0.625	0.367	0.275
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	0.088	0.188	0.715	0.367	0.275
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.077	-0.166	0.64	-0.129	-0.075
Total Liabilities & Shareholders' Equity	0.011	0.022	1.35	0.238	0.2
Total Common Shares Outstanding